Log In
BCIQ
Print this Print this
 

SNX9 class

  Manage Alerts
Collapse Summary General Information
Company Senex Biotechnology Inc.
DescriptionCyclin dependent kinase (CDK) pathway inhibitor
Molecular Target Cyclin dependent kinase (CDK)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today